Navigation Links
Jefferson is first academic medical center to offer FDA-approved BRAF mutation for melanoma patients
Date:11/8/2011

PHILADELPHIAThomas Jefferson University Hospital is the first academic medical center in the United States to offer the recently-approved U.S. Food and Drug Administration (FDA) diagnostic tool that tests melanoma patients for the BRAF mutation (which occurs in about half of all cases) and ultimately determines if they'll benefit from a new, potentially life-saving drug.

In August, the FDA approved the oral drug vemurafenib to treat patients whose melanoma cells have the BRAF V600E mutation, as determined by the companion diagnostic test, after clinical trials showed that the drug significantly extended survival in metastatic melanoma patients with the mutation.

Jefferson's clinical laboratories have officially begun utilizing the FDA-approved test to help determine melanoma patients' status and a subsequent and immediate treatment plan. According to Roche Diagnostics, its tool has improved sensitivity, accuracy and speed compared to other commonly used detection methods.

"It is very important to us at Jefferson to offer patients a personalized approach, starting with the pathology of their diseases all the way through their treatment," says Stephen C. Peiper, M.D., Peter A. Herbut Professor and Chair of the Department of Pathology, Anatomy and Cell Biology at Thomas Jefferson University.

"Melanoma is a deadly skin cancer, and this FDA-approved diagnostic tool plays a pivotal role in our approach to it. The BRAF mutation test will allow us to quickly and accurately identify patients here at the hospital who will respond positively to this new treatment," he adds.

An estimated 50 percent of patients with melanoma have this type of mutation.

The FDA approval of vemurafenib is based on results from two clinical studies in people with BRAF V600E mutation-positive, inoperable or metastatic melanoma as determined by the mu
'/>"/>

Contact: Steve Graff
stephen.graff@jefferson.edu
215-955-5291
Thomas Jefferson University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Thomas Jefferson University Hospital cuts Whipple procedure wound infections in half with new measures
2. Jefferson physician named an Educator of the Year by the Assocociation of Residents in Radiation Oncology
3. Thomas Jefferson University Hospital adopts new imaging agent to improve detection of bladder cancer
4. Thomas Jefferson University and hospitals tasked to find new radiation drugs
5. FDA approval of brain aneurysm device gives Jefferson neurosurgeons another life-saving tool
6. Jefferson doctors strengthen case for high-dose radiotherapy technique after radical prostatectomy
7. Kimmel Cancer Center at Jefferson breast cancer symposium features latest in research, treatment
8. Jefferson clinical trial: Can a cholesterol drug prevent colon cancer?
9. Thomas Jefferson University professor elected AAAS Fellow
10. Jefferson study determines bone marrow stromal stem cells may aid in stroke recovery
11. CancerCare names Jefferson professor Physician of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Connor Sports has produced six ... in Spain at the Barcelona, Bilbao, Gran Canaria, Granada, ... & Venue Centre Partner since 1994 and Official Technical Supplier ... will bear the Connor Sports logo and tagline “Where Champions ... the ESPN broadcasts of the FIBA World Cup. , “Connor ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 When Jagger was ... call from his mother; one that he credits as one ... His mom had news that she could set him up ... people with disabilities. Jagger took that job, and he has ... Throughout these past two decades, he also worked in school ...
(Date:8/27/2014)... News) -- Overconfident people are better at convincing others ... therefore are more likely to get promotions and reach ... added that these "self-deceived" people are also more likely ... risks. And finally, people who underestimate themselves are ... the British researchers. Their findings were published Aug. 27 ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 CarePoint ... pediatric practice, Hoboken Pediatrics has joined our network, ... Andrzej Klos, Dr. Piotr Oko, Dr. Yanina Meshko ... of highly skilled and experienced physicians comprise CarePoint ... doctors and practices in Hudson County, representing a ...
(Date:8/27/2014)... Georgia State University’s Center for Leadership in ... from the Maternal and Child Health Bureau of ... implementation of the Autism Plan for Georgia, aimed ... autism spectrum disorder. , In preparing for this ... composed of key stakeholders from across Georgia. The ...
Breaking Medicine News(10 mins):Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 2Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4Health News:Overconfident Folks May Blind Others to Their Real Abilities 2Health News:Hoboken Pediatrics Joins CarePoint Health Medical Group 2Health News:Hoboken Pediatrics Joins CarePoint Health Medical Group 3Health News:Center for Leadership in Disability Awarded $600,000 Grant to Improve Services for Georgia’s Children and Youth with Autism 2
... by Suresh Alahari, PhD, Associate Professor of Biochemistry and Molecular ... for the first time that a tiny piece of RNA ... invasive breast cancer and identified a gene that appears to ... August 21, 2009 issue of the Journal of Biological ...
... New test could lead to clearer glass for hand-held ... touch screens of BlackBerrys and iPhones tend to smudge ... determine the chemical composition and the effectiveness of protective ... of better anti-smudge, anti-reflective coverings. , The key to ...
... at an all-time low, new government report shows, , WEDNESDAY, ... States has reached almost 78 years, a record high, federal ... increased, but the death rate has dropped to an all-time ... new report from the U.S. Centers for Disease Control and ...
... the biggest challenges in scientists, quest to develop new and ... how and why cancer spreads. Recent breakthroughs have uncovered ... the molecular level, but much remains to be understood about ... developed by Klaus Hahn, Ph.D. and his colleagues uses light ...
... WASHINGTON, Aug. 19 The following is a statement ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) , ... today that it is establishing the Center for Tobacco Products and ... public health leader, as the Center Director is a demonstration of ...
... ... , ... 2009 -- Scientists from the U.S. Department of Energy,s (DOE) Argonne National Laboratory ... cancer cells using inorganic titanium dioxide nanoparticles bonded to soft biological material., , , , ...
Cached Medicine News:Health News:LSUHSC research discovers new targets for treatment of invasive breast cancer 2Health News:A Smudge-Free Smart Phone Screen? 2Health News:Life Expectancy in U.S. Hits a New High 2Health News:Life Expectancy in U.S. Hits a New High 3Health News:Tobacco-Free Kids Welcomes Formation of FDA's Center for Tobacco Products and Selection of Center Director 2Health News:Argonne, University of Chicago Scientists Develop Targeted Cancer Treatment Using Nanomaterials 2Health News:Argonne, University of Chicago Scientists Develop Targeted Cancer Treatment Using Nanomaterials 3
(Date:8/27/2014)... Aug. 27, 2014  Columbia Laboratories, Inc. (Nasdaq: ... of pharmaceutical development, clinical trial manufacturing, and advanced analytical ... that it will participate at the upcoming Rodman & ... be held in New York . ... on September 9, 2014 at the New York Palace ...
(Date:8/27/2014)... and NINGBO, China , Aug. ... Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") today announced they ... of generic pharmaceuticals, primarily targeting the United ... agreement, Amerigen and Menovo will jointly develop products for ... . Menovo will be responsible for manufacturing API ...
(Date:8/27/2014)... Aug. 27, 2014 /CNW/ - Covalon Technologies Ltd. (the "Company" ... the following financial results for its third quarter of fiscal ... 2014: , Revenue of $1,291,378, a 13% decrease ... Net loss for the quarter of $240,156 compared to net ... year For the nine months ended June ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3
... from Biodel Inc. (Nasdaq: BIOD ) reported ... basal insulin and stabilized glucagon development programs in poster ... Technology Meeting in Bethesda, MD.   Dr. ... double-blind, randomized crossover trial in 13 subjects with type ...
... (NYSE Amex: NBS ) ("NeoStem" or the ... revenues, global research and development capabilities and operations in ... adult stem cells, and China pharmaceuticals, is today providing ... Third Quarter Results Revenues for the nine ...
Cached Medicine Technology:Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 2Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 3Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 4Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 5NeoStem Provides Third Quarter Update 2NeoStem Provides Third Quarter Update 3
Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed....
A unique system for secure fixation of the cranial bone flap after craniotomy. Craniofix eliminates the need for mini plates, screws, and additional drills....
1.0 mm Micro System. The Titanium Micro System is also useful in the practice of ENT, Neurosurgery and Handsurgery....
... Cable System, designed for ... sublaminar interspinous fixation, non-displaced ... sternotomy closure. Consists of ... complete set of instruments ...
Medicine Products: